Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jun 22;101(25):9435-40.
doi: 10.1073/pnas.0400569101. Epub 2004 Jun 14.

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

Eric J Benner  1 , R Lee Mosley, Chris J Destache, Travis B Lewis, Vernice Jackson-Lewis, Santhi Gorantla, Craig Nemachek, Steven R Green, Serge Przedborski, Howard E Gendelman
Affiliations

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

Eric J Benner et al. Proc Natl Acad Sci U S A. .

Abstract

Degeneration of the nigrostriatal dopaminergic pathway, the hallmark of Parkinson's disease, can be recapitulated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. Herein, we demonstrate that adoptive transfer of copolymer-1 immune cells to MPTP recipient mice leads to T cell accumulation within the substantia nigra pars compacta, suppression of microglial activation, and increased local expression of astrocyte-associated glial cell line-derived neurotrophic factor. This immunization strategy resulted in significant protection of nigrostriatal neurons against MPTP-induced neurodegeneration that was abrogated by depletion of donor T cells. Such vaccine treatment strategies may provide benefit for Parkinson's disease.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
MPTP-induced immunotoxicity. (A and B) Seven days after MPTP intoxication, spleen size (A) and CD3+ T lymphocyte numbers (B) were reduced in spleens of MPTP-treated mice. (C) Flow cytometric analysis of splenocytes from PBS (Left) and MPTP (Right) 2 days after intoxication.
Fig. 2.
Fig. 2.
Cop-1 immunization protects against MPTP-induced dopaminergic neuronal loss. (A) Photomicrographs of SNpc and striatum TH immunostaining from PBS, MPTP, MPTP/Cop-1, or MPTP/OVA groups. (B) SNpc TH+ neuronal counts of SNpc TH+ neurons. (C) Optical densities of striatal TH+ fibers. Values represent means ± SEM for five to nine mice per group. P < 0.05 compared with PBS (a), MPTP (b), and MPTP/OVA (b).
Fig. 3.
Fig. 3.
Cytokine secretion by Cop-1 donor immune cells and T cell infiltration of the SNpc. (A and B) IL-10 (A) and IL-4 (B) secretion by Cop-1-immunized splenocytes cultured in media or stimulated with Cop-1 or MBP (30 μg/ml). Values are means of IL-10 or IL-4 concentrations ± SEM for three to four mice. a, P < 0.05 compared with PBS treatment group. (C) CD3+ T cells in the SNpc of MPTP-intoxicated mice 2 days after adoptive transfer of Cop-1 splenocytes (arrows). (D) CD3+ T cells in proximity (green) to TH+ neurons (red) within the SNpc of an MPTP mouse. (E) Western blot analysis for IgG in ventral midbrains after adoptive transfer of splenocytes. (F) Ventral midbrain CD3+ T cells (green) in direct contact with Mac-1+ cells (red; magnification: ×2,000).
Fig. 4.
Fig. 4.
Cop-1 immunization reduces MPTP-induced microglial reaction in the SNpc. (A–D) Mac-1 immunostaining within the SNpc (area circumscribed by dashed line and Insets at ×100 magnification) from PBS (A), MPTP (B), MPTP/Cop-1 (C), or MPTP/OVA (D) groups. (E) Real-time RT-PCR assessment of Mac-1/GAPDH mRNA from ventral midbrain. (F) Counts of Mac-1+-reactive microglia from SNpc. P < 0.05 compared with PBS (a), MPTP (b), and MPTP/OVA (b) groups.
Fig. 5.
Fig. 5.
T cell depletion ablates Cop-1-mediated dopaminergic neuroprotection. (A) Flow cytometric analysis of Cop-1 immune splenocytes before (unfractionated) and after T cell depletion. (B) Counts of SNpc TH+ neurons for PBS (n = 5), MPTP (n = 7), MPTP/Cop-1 (n = 8), MPTP/OVA (n = 8), and MPTP/Cop-1/T cell-depleted groups (n = 6). (C) Densities of striatal TH+ fibers. Values are means ± SEM. P < 0.01 compared with PBS (a), MPTP (b), and MPTP/OVA (b), MPTP/Cop-1/T (b)-depleted groups.
Fig. 6.
Fig. 6.
GDNF expression in MPTP-intoxicated mice after adoptive transfer of Cop-1 splenocytes. (A) Real-time RT-PCR of GDNF mRNA expression from ventral midbrains of PBS, MPTP, MPTP/Cop-1, or MPTP/OVA groups. Values represent ratios of GDNF mRNA normalized to GAPDH and are means ± SEM for five to six mice per group. P < 0.05 compared with PBS (a), MPTP, and MPTP/OVA groups. (B–F) Confocal microscopy of SNpc from MPTP-treated recipients of splenocytes from Cop-1-immunized mice showing GDNF immunostaining (red) (B–D and F) and Mac-1+ (green) microglia (B), CD3+ (green) T cells (C), and GFAP+ (green) astrocytes (D and F). Magnification: ×2000.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fahn, S. & Przedborski, S. (2000) Merritt's Neurology (Lippincott, Williams & Wilkins, New York).
    1. Dauer, W. & Przedborski, S. (2003) Neuron 39, 889-909. - PubMed
    1. Chen, H., Zhang, S. M., Hernan, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E. & Ascherio, A. (2003) Arch. Neurol. (Chicago) 60, 1059-1064. - PubMed
    1. Gao, H. M., Liu, B., Zhang, W. & Hong, J. S. (2003) Trends Pharmacol. Sci. 24, 395-401. - PubMed
    1. McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. (1988) Neurology 38, 1285-1291. - PubMed

Publication types

MeSH terms

LinkOut - more resources

-